Your browser doesn't support javascript.
loading
Immunoglobulin and Complement Immunohistochemistry on Paraffin Sections in Autoimmune Bullous Diseases: A Systematic Review and Meta-analysis.
Kasperkiewicz, Michael; Lai, Olivia; Kim, Gene; DeClerck, Brittney; Woodley, David T; Zillikens, Detlef; Recke, Andreas.
Afiliação
  • Kasperkiewicz M; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Lai O; Department of Dermatology, University of Illinois at Chicago, Chicago, IL; and.
  • Kim G; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • DeClerck B; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Woodley DT; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Zillikens D; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Recke A; Department of Dermatology, University of Lübeck, Lübeck, Germany.
Am J Dermatopathol ; 43(10): 689-699, 2021 Oct 01.
Article em En | MEDLINE | ID: mdl-33055534
ABSTRACT
ABSTRACT Immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded tissue has been proposed as a potential tool in the diagnosis of autoimmune bullous diseases (AIBDs) in lieu of standard direct immunofluorescence (DIF) microscopy. To comprehensively determine the diagnostic accuracy of immunoglobulin and complement IHC for diagnosis of AIBDs, we conducted a systematic review and multivariate Bayesian model-based meta-analysis of the literature. Quality and heterogeneity assessment of studies was performed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) checklist and the I2 index, respectively. Electronic searches using PubMed from April 1964 to July 2020 identified 14 articles meeting predetermined inclusion and exclusion criteria. Median sensitivities with 95% credible intervals in pemphigus and pemphigoid were 0.24 (0.01-0.89) and 0.22 (0.02-0.77) with immunoglobulin G (IgG), 0.77 (0.39-0.95) and 0.25 (0.02-0.85) with IgG4, 0.11 (0.02-0.32) and 0.86 (0.56-0.98) with C3d, and 0.84 (0.56-0.97) and 0.75 (0.37-0.94) with C4d, respectively. Specificities were 1.00 (0.00-1.00) with IgG, 0.98 (0.89-1.00) with IgG4, 0.99 (0.97-1.00) with C3d, and 0.99 (0.97-1.00) with C4d. The risk of bias and heterogeneity among studies was a serious problem, decreasing the level of evidence. Our work suggests that, in selected cases, paraffin-based IHC may be a helpful procedure to screen for AIBDs, especially when specialized laboratories and/or biopsy specimens for DIF do not exist. Nevertheless, more studies with a refined quality design are needed to explore the true usefulness of this diagnostic method in AIBDs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Doenças Autoimunes / Imunoglobulina G / Complemento C3d / Complemento C4b / Dermatopatias Vesiculobolhosas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Am J Dermatopathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Doenças Autoimunes / Imunoglobulina G / Complemento C3d / Complemento C4b / Dermatopatias Vesiculobolhosas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Am J Dermatopathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá